Literature DB >> 23400327

Sca-1-positive cardiac stem cell migration in a cardiac infarction model.

Jingjin Liu1, Yongshun Wang, Wenjuan Du, Bo Yu.   

Abstract

Adult myocardium has the capacity for repair and regeneration, which is derived from cardiac stem cells (CSCs). In this study, we assessed the migration and changes in numbers of Sca-1-positive CSCs after myocardial infarction (MI) in vivo and in vitro. In this study, we showed that in a rat MI model the CSCs emerged around the vessels near the peri-infarct zone and in the epicardium of the infarcted area. Four weeks after infarction, no differences in the expression of connexin 43 (Cx43) were observed in the peri-infarct and infarct zones. In vitro, we mimicked tissue ischemia and hypoxia by using a culture environment of 5 % O₂ and a wound healing assay to monitor the migration of CSCs. In conclusion, under hypoxic conditions, the CSCs, conveyed by blood vessels, migrated from the niche to the infarct zone for repairing the damaged myocytes. The number of endogenous migrating CSCs was proportionate to the repair time after infarction, rather than the degree of infarction. Four weeks after MI, the expression of Cx43 was not altered in migratory CSCs, namely no enhanced gap-junctional communication with cardiomyocytes was seen in the CSCs. Further studies are necessary to delineate the molecular mechanisms that drive the migration of CSCs after MI.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400327     DOI: 10.1007/s10753-013-9600-8

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  15 in total

1.  The post-natal heart contains a myocardial stem cell population.

Authors:  Andrée M Hierlihy; Patrick Seale; Corrinne G Lobe; Michael A Rudnicki; Lynn A Megeney
Journal:  FEBS Lett       Date:  2002-10-23       Impact factor: 4.124

2.  Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes.

Authors:  Katsuhisa Matsuura; Toshio Nagai; Nobuhiro Nishigaki; Tomomi Oyama; Junichiro Nishi; Hiroshi Wada; Masanori Sano; Haruhiro Toko; Hiroshi Akazawa; Toshiaki Sato; Haruaki Nakaya; Hiroshi Kasanuki; Issei Komuro
Journal:  J Biol Chem       Date:  2003-12-31       Impact factor: 5.157

3.  Adult cardiac stem cells are multipotent and support myocardial regeneration.

Authors:  Antonio P Beltrami; Laura Barlucchi; Daniele Torella; Mathue Baker; Federica Limana; Stefano Chimenti; Hideko Kasahara; Marcello Rota; Ezio Musso; Konrad Urbanek; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Piero Anversa
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

4.  Franklin H. Epstein Lecture. Cardiac development and implications for heart disease.

Authors:  Jonathan A Epstein
Journal:  N Engl J Med       Date:  2010-10-21       Impact factor: 91.245

5.  Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function.

Authors:  Axel Linke; Patrick Müller; Daria Nurzynska; Claudia Casarsa; Daniele Torella; Angelo Nascimbene; Clotilde Castaldo; Stefano Cascapera; Michael Böhm; Federico Quaini; Konrad Urbanek; Annarosa Leri; Thomas H Hintze; Jan Kajstura; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

6.  Human cardiac stem cells.

Authors:  Claudia Bearzi; Marcello Rota; Toru Hosoda; Jochen Tillmanns; Angelo Nascimbene; Antonella De Angelis; Saori Yasuzawa-Amano; Irina Trofimova; Robert W Siggins; Nicole Lecapitaine; Stefano Cascapera; Antonio P Beltrami; David A D'Alessandro; Elias Zias; Federico Quaini; Konrad Urbanek; Robert E Michler; Roberto Bolli; Jan Kajstura; Annarosa Leri; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

7.  Expansion of acute myocardial infarction: an experimental study.

Authors:  J S Hochman; B H Bulkley
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

Review 8.  Cardiac stem cell-based myocardial regeneration: towards a translational approach.

Authors:  Daniele Torella; Ciro Indolfi; David F Goldspink; Georgina M Ellison
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-01

9.  HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells.

Authors:  Alessandra Rossini; Antonella Zacheo; David Mocini; Pierangela Totta; Antonio Facchiano; Raffaella Castoldi; Paolo Sordini; Giulio Pompilio; Damiano Abeni; Maurizio C Capogrossi; Antonia Germani
Journal:  J Mol Cell Cardiol       Date:  2008-02-13       Impact factor: 5.000

10.  Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK.

Authors:  Dong Kuang; Xia Zhao; Guixiang Xiao; Juan Ni; Youmei Feng; Renliang Wu; Guoping Wang
Journal:  Basic Res Cardiol       Date:  2007-12-17       Impact factor: 17.165

View more
  16 in total

1.  Adaptive inflammatory microenvironment for cell-based regeneration in ischemic cardiovascular disease.

Authors:  Weiwei Fan; Jibin Zhang; Zheng Zhang; Qiong Wang; Feng Cao
Journal:  Organogenesis       Date:  2013-07-03       Impact factor: 2.500

2.  In vitro and in vivo analysis of visible light crosslinkable gelatin methacryloyl (GelMA) hydrogels.

Authors:  Iman Noshadi; Seonki Hong; Kelly E Sullivan; Ehsan Shirzaei Sani; Roberto Portillo-Lara; Ali Tamayol; Su Ryon Shin; Albert E Gao; Whitney L Stoppel; Lauren D Black; Ali Khademhosseini; Nasim Annabi
Journal:  Biomater Sci       Date:  2017-09-26       Impact factor: 6.843

3.  Cardiac stem cells: translation to human studies.

Authors:  Zijun Ge; Sean Lal; Thi Y L Le; Cris Dos Remedios; James J H Chong
Journal:  Biophys Rev       Date:  2014-12-03

4.  Intramyocardial Delivery of Notch Ligand-Containing Hydrogels Improves Cardiac Function and Angiogenesis Following Infarction.

Authors:  Archana V Boopathy; Mario D Martinez; Amanda Walker Smith; Milton E Brown; Andrés J García; Michael E Davis
Journal:  Tissue Eng Part A       Date:  2015-07-13       Impact factor: 3.845

5.  Cardiac Stem Cell Secretome Protects Cardiomyocytes from Hypoxic Injury Partly via Monocyte Chemotactic Protein-1-Dependent Mechanism.

Authors:  Chi-Yeon Park; Seung-Cheol Choi; Jong-Ho Kim; Ji-Hyun Choi; Hyung Joon Joo; Soon Jun Hong; Do-Sun Lim
Journal:  Int J Mol Sci       Date:  2016-05-24       Impact factor: 5.923

6.  Age-Dependent Effect of Pediatric Cardiac Progenitor Cells After Juvenile Heart Failure.

Authors:  Udit Agarwal; Amanda W Smith; Kristin M French; Archana V Boopathy; Alex George; David Trac; Milton E Brown; Ming Shen; Rong Jiang; Janet D Fernandez; Brian E Kogon; Kirk R Kanter; Baahaldin Alsoufi; Mary B Wagner; Manu O Platt; Michael E Davis
Journal:  Stem Cells Transl Med       Date:  2016-05-05       Impact factor: 6.940

7.  MiR218 Modulates Wnt Signaling in Mouse Cardiac Stem Cells by Promoting Proliferation and Inhibiting Differentiation through a Positive Feedback Loop.

Authors:  Yongshun Wang; Jingjin Liu; Jinjin Cui; Meng Sun; Wenjuan Du; Tao Chen; Xing Ming; Lulu Zhang; Jiangtian Tian; Ji Li; Li Yin; Fang Liu; Zhongyue Pu; Bo Lv; Jingbo Hou; Bo Yu
Journal:  Sci Rep       Date:  2016-02-10       Impact factor: 4.379

8.  ERK1/2 pathway regulates coxsackie and adenovirus receptor expression in mouse cardiac stem cells.

Authors:  Jingjin Liu; Qiang Sun; Yongshun Wang; Jinjin Cui; Maomao Zhang; Lili Li; Haibo Jia; Lulu Zhang; Bin Zhu; Miaomiao Jiang; Bo Yu; Shuo Zhang
Journal:  Exp Ther Med       Date:  2017-05-02       Impact factor: 2.447

9.  The impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart development.

Authors:  Jon Sin; Jenna M Puccini; Chengqun Huang; Mathias H Konstandin; Paul E Gilbert; Mark A Sussman; Roberta A Gottlieb; Ralph Feuer
Journal:  PLoS Pathog       Date:  2014-07-31       Impact factor: 6.823

10.  Up-Regulation of miRNA-21 Expression Promotes Migration and Proliferation of Sca-1+ Cardiac Stem Cells in Mice.

Authors:  Qingling Zhou; Qiang Sun; Yongshan Zhang; Fei Teng; Jinhui Sun
Journal:  Med Sci Monit       Date:  2016-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.